E
Bicycle Therapeutics plc BCYC
$8.52 -$0.08-0.93% NASDAQ
Recommendation
Prev Close
$8.60
Volume
166,423
Avg Vol (90D)
463,811
Market Cap
$595.14M
Dividend & Yield
--
52-Week Range
$6.10 - $28.67
P/E (TTM)
--
EPS (TTM)
-$2.88
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Bicycle Therapeutics (NASDAQ:BCYC) Stock Price Up 9.3% - Time to Buy?
4/24/2025 - MarketBeat
Bicycle Therapeutics (BCYC, $8.73) price may drop as it broke higher Bollinger Band on Apr 22, 2025
4/23/2025 - Tickeron - Stocks
Bicycle Therapeutics plc (BCYC, $7.51) entered Uptrend as Momentum indicator ascends above 0 level on Apr 21, 2025
4/22/2025 - Tickeron - Stocks
Bicycle Therapeutics: Maybe Underwhelming, But I Don't Think They Should Be This Discounted
4/22/2025 - SeekingAlpha
Bicycle Therapeutics: Maybe Underwhelming, But I Don't Think They Should Be This Discounted
4/22/2025 - Seeking Alpha - Long Ideas
Nan Fung Group Holdings Ltd Acquires 37,358 Shares of Bicycle Therapeutics plc (NASDAQ:BCYC)
4/21/2025 - MarketBeat
Bicycle Therapeutics plc (NASDAQ:BCYC) Receives Consensus Rating of "Moderate Buy" from Brokerages
4/21/2025 - MarketBeat
Altium Capital Management LLC Cuts Position in Bicycle Therapeutics plc (NASDAQ:BCYC)
4/20/2025 - MarketBeat
Nan Fung Group Holdings Ltd Has $965,000 Stake in Bicycle Therapeutics plc (NASDAQ:BCYC)
4/19/2025 - Ticker Report
Bicycle Therapeutics (NASDAQ:BCYC) Shares Gap Up - Still a Buy?
4/17/2025 - MarketBeat
Bicycle Therapeutics (NASDAQ:BCYC) Shares Gap Up - Still a Buy?
4/17/2025 - Ticker Report
Bicycle Therapeutics (BCYC, $7.79) Moving Average Convergence Divergence (MACD) Histogram turned positive on April 15, 2025
4/16/2025 - Tickeron - Stocks
Bicycle Therapeutics (BCYC, $7.79) Stochastic Oscillator left the oversold zone on April 15, 2025
4/16/2025 - Tickeron - Stocks
Bicycle Therapeutics (BCYC, $7.07) RSI Indicator left the oversold zone on April 14, 2025
4/15/2025 - Tickeron - Stocks
Bicycle Therapeutics' (BCYC) "Buy" Rating Reiterated at Needham & Company LLC
4/11/2025 - MarketBeat
The volume for Bicycle Therapeutics stock increased for one day, resulting in a record-breaking daily growth of 237% of the 65-Day Volume Moving Average
4/10/2025 - Tickeron - Stocks
Analyst Expectations For Bicycle Therapeutics's Future
4/9/2025 - Benzinga
Kevin Lee Sells 2,237 Shares of Bicycle Therapeutics plc (NASDAQ:BCYC) Stock
4/7/2025 - Ticker Report
Insider Selling: Bicycle Therapeutics plc (NASDAQ:BCYC) CEO Sells 2,237 Shares of Stock
4/7/2025 - MarketBeat
Bicycle Therapeutics (BCYC, $7.43) price may climb as it broke lower Bollinger Band on Apr 03, 2025
4/4/2025 - Tickeron - Stocks
Bicycle Therapeutics (BCYC, $7.85) Moving Average Convergence Divergence (MACD) Histogram turned negative on April 1, 2025
4/2/2025 - Tickeron - Stocks
Bicycle Therapeutics (BCYC, $7.85) price may climb as it broke lower Bollinger Band on Apr 01, 2025
4/2/2025 - Tickeron - Stocks
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4/2/2025 - GuruFocus
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4/2/2025 - Business Wire
Bicycle Therapeutics (NASDAQ:BCYC) Sets New 12-Month Low - Should You Sell?
4/1/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$35.28M
EBITDA (TTM)
-$202.70M
EBIT (TTM)
-$209.87M
Net Income (TTM)
-$169.03M
Balance Sheet
Total Assets (Q)
$956.87M
Total Debt (Q)
$13.48M
Total Liabilities (Q)
$163.81M
Book Value Per Share (Q)
$11.48
Cash Flow
Cash from Operations (TTM)
-$164.72M
Cash from Investing (TTM)
-$1.24M
Cash from Financing (TTM)
$519.75M
Net Change in Cash (TTM)
$353.10M
Filings
Filing Date
Tuesday, February 25, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Beginning of May (est)
Price History
Loading...
Beta
0.82
7-Day Total Return
9.37%
30-Day Total Return
-11.53%
60-Day Total Return
-34.36%
90-Day Total Return
-57.63%
Year to Date Total Return
-40.67%
1-Year Total Return
-62.17%
2-Year Total Return
-57.29%
3-Year Total Return
-66.84%
5-Year Total Return
-42.86%
52-week Low
Apr 09, 2025 - $6.10
52-week High
Oct 16, 2024 - $28.67
Valuation
Market Cap
$595.14M - Small Cap
Enterprise Value
-$274.89M
Price/Sales (TTM)
16.84
Price/Book (Q)
0.75
Dividends and Shares
Shares Outstanding
69.05M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.bicycletherapeutics.com
Phone Number
44 1223 261 503
Address
Portway Building
Blocks A & B - Granta Park
Great Abington Cambridge, CB21 6GS
Country
United Kingdom
Year Founded
2009
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Bicycle Therapeutics plc, a clinical-stage pharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics in the United States and the United... more
NASDAQ 04/25/2025 2:20PM Eastern Quotes delayed